Commentary · 8 Jun 2026
Conference abstractPublished 27 Oct 2015
Efficacy and safety of MMFS-01, a synapse density enhancer, for reversing age-related cognitive decline: A randomized, double-blind, placebo-controlled trial
Neurocentria, USA The Ohio State University, USA University of Southern California, USA Tsinghua University, China
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Age-related cognitive decline is a major problem in elderly, affecting quality of life. Pre-clinical studies show that MMFS-01, a synapse density enhancer, is effective at reversing cognitive decline in aging rodents. Objective: Since brain atrophy during aging is strongly associated with both cognitive decline and sleep disorder, we evaluated the efficacy of MMFS-01 in its ability to reverse cognitive decline and improve sleep. Methods: We conducted a randomized, double-blind, placebo-controlled, parallel designed trial in elderly subjects (age 50- 70) with complaints of memory impairment, sleep disorder, and anxiety. Subjects were treated with MMFS-01 (n=23) or placebo (n=21) for 12 weeks and cognitive ability, sleep quality, and emotion were evaluated. Overall cognitive ability was determined by a composite score of tests in four major cognitive domains. Results: With MMFS-01 treatment, overall cognitive ability improved significantly relative to placebo (p=0.002; CohenâÂ?Â?s d=0.92). Age-related cognitive fluctuation was also reduced. Although the study population had more severe executive function deficits than age-matched controls, MMFS-01 treatment nearly restored impaired executive function, demonstrating that MMFS-01 was clinically significant. Sleep quality and anxiety were improved in MMFS-01 treatment group; however, similar degrees of improvement were also observed in the placebo control group. Conclusions: The current study demonstrates the potential of MMFS-01 for treating age-related cognitive decline in elderly.
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Alzheimers Disease & Parkinsonism.
Perspective · 8 Jun 2026
Oxidative Stress and Its Role in Neuronal Degeneration: Mechanisms and Implications
Commentary · 8 Jun 2026
Understanding the Pathophysiology of Prion-Induced Dementia
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Alzheimers Disease & Parkinsonism
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Guosong Liu”
- BylineArticles whose byline prints “Jason G Weinger”
- BylineArticles whose byline prints “Zhong-Lin Lu”
- BylineArticles whose byline prints “Feng Xue”
- BylineArticles whose byline prints “Safa Sadeghpour”